TransMedics Group, Inc. (BIT:1TMDX)
Italy flag Italy · Delayed Price · Currency is EUR
116.60
0.00 (0.00%)
Last updated: Oct 31, 2025, 9:00 AM CET

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212015 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2015 - 2020
United States Lung Revenue
14.60M15.76M
Log In
Log In
Log In
Upgrade
United States Heart Revenue
110.58M96.66M
Log In
Log In
Log In
Upgrade
United States Liver Revenue
421.29M309.46M
Log In
Log In
Log In
Upgrade
United States OCS Transplant Revenue
546.46M421.88M
Log In
Log In
Log In
Upgrade
All Other Countries Lung Revenue
1.52M1.93M
Log In
Log In
Log In
Upgrade
All Other Countries Heart Revenue
13.63M13.20M
Log In
Log In
Log In
Upgrade
All Other Countries Liver Revenue
600.00K158.00K
Log In
Log In
Log In
Upgrade
All Other Countries OCS Transplant Revenue
15.75M15.28M
Log In
Log In
Log In
Upgrade
Total OCS Transplant Revenue
562.95M437.16M
Log In
Log In
Log In
Upgrade
Other Service Revenue
-4.38M
Log In
Log In
Log In
Upgrade
Revenue (Other)
-1.12B-874.32M
Log In
Log In
Log In
Upgrade
Revenue (Total)
566.35M441.54M
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212015 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2015 - 2020
Net Product Revenue
346.96M273.87M
Log In
Log In
Log In
Upgrade
Service Revenue
219.40M167.67M
Log In
Log In
Log In
Upgrade
Revenue (Total)
566.35M441.54M
Log In
Log In
Log In
Upgrade
Updated Sep 30, 2025. Data Source: Fiscal.ai.